Research

Mixed

Contemporary obesity management medications (OMMs) like semaglutide and tirzepatide cause significant lean mass loss (25-40% of weight lost), necessitating specific lifestyle interventions (resistance training and adequate protein) to mitigate muscle loss and maintain metabolic health.

If you are taking a GLP-1 or similar weight loss medication, expect to lose some muscle along with fat. To protect your strength and metabolism, prioritize resistance training and ensure you are eating enough protein. These lifestyle steps are critical complements to the medication.

ModerateSupportsMEDIUM confidence
It has been estimated that reductions in lean mass after 1-year of sustained semaglutide and/or tirzepatide use can range from 25-40%... Two potential lifestyle strategies recommended include (1) ensuring adequate protein intake and (2) engaging in progressive resistance training.
Renee J. Rogers et al. · American Journal of Health Promotion · 2025

Why this rating

Based on estimates and comparisons to other weight loss modalities; the paper explicitly states no clinical trials have directly measured this specific interaction.

Source

The Critical Role of Lifestyle With the Use of Contemporary Obesity Management Medications

Renee J. Rogers et al. · American Journal of Health Promotion · 2025

DOI 10.1177/08901171251335507c

narrative_reviewCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →